This is a unique comparison because Epithalon and Epitalon are the same compound. The naming confusion has caused significant misunderstanding in the peptide community, with some people believing they are two different molecules with different effects. They are not.
Why Two Names Exist
The peptide was developed by Professor Vladimir Khavinson at the Saint Petersburg Institute of Bioregulation and Gerontology in Russia. The original Russian name is "Эпиталон" (Epitalon). When transliterated into English, different conventions produced different spellings:
- Epitalon — a more direct transliteration of the Russian
- Epithalon — an anglicized variant that became common in Western peptide markets
Other names you may encounter include Epithalone and AEDG peptide (from its amino acid sequence: Ala-Glu-Asp-Gly). All refer to the same molecule.
How It Works
Epithalon/Epitalon is a synthetic version of Epithalamin, a polypeptide naturally produced by the pineal gland. Its primary studied mechanism is activation of telomerase, the enzyme responsible for maintaining and lengthening telomeres — the protective caps at the ends of chromosomes that shorten with each cell division and are considered a biomarker of biological aging.
By activating telomerase, Epithalon may slow or partially reverse telomere shortening, theoretically extending cellular lifespan. Additionally, it has been shown to regulate melatonin production and normalize circadian rhythm function through its action on the pineal gland.
What the Research Shows
Professor Khavinson's research spans over three decades. Key findings include:
- Cell culture studies: Epithalon increased the number of cell divisions beyond the Hayflick limit in human fibroblast cultures and activated telomerase expression.
- Animal studies: Treated mice and rats showed a 13-31% increase in median lifespan compared to controls. Tumor incidence was reduced.
- Human observational data: An elderly cohort given Epithalamin (the natural precursor) over 6 years showed a 1.6-1.8x reduction in mortality rate compared to controls.
The primary limitation of Epithalon research is that most studies were conducted in Russian institutions, and large-scale, Western-standard randomized controlled trials have not yet been completed.
Dosing Protocol
The standard protocol used in research and clinical practice:
- Dose: 5-10 mg per day
- Route: Subcutaneous injection
- Duration: 10-20 consecutive days
- Frequency: 1-2 cycles per year
- Timing: Evening administration (to align with pineal gland circadian activity)
What to Look for When Purchasing
Since the compound is the same regardless of the name, focus on:
- Purity testing: Demand third-party HPLC and mass spectrometry certificates showing purity above 98%.
- Source reputation: Purchase from established peptide suppliers with transparent testing.
- Storage: Epithalon should be stored lyophilized (freeze-dried) at -20C and reconstituted with bacteriostatic water before use.